News

The fake cough syrup was laced with NRx medicine such as Alprazolam and Clonazepam and labelled as Codeine Syrup by putting false labels of reputed companies.
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...
The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE Therapeutics, is expected ...
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...
NRX-100, a preservative-free ketamine, is also under an Abbreviated New Drug Application (“ANDA”) with a priority review ...
Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
NRx Pharmaceuticals (NASDAQ: NRXP) has filed for the newly launched FDA Commissioner's National Priority Voucher (CNPV) program, seeking accelerated ...
Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2025 Earnings Call Transcript May 16, 2025 Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx Pharmaceuticals First Quarter 2025 ...
Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx Pharmaceuticals First Quarter 2025 Earnings Call. At this time, all lines are in a listen-only mode.
Deployed capital to meet the objectives listed below NRX-100 planned to complete New Drug Application filing in Q2 2025, with expected 2025 PDUFA date; $4.3 million NDA submission fee waived by ...